The latest update is out from Ainos (AIMD).
On June 14, 2024, Ainos, Inc. announced updated bylaws and significant advancements in their Ainos Flora clinical trials, highlighting future plans involving NVIDIA CUDA technology. The changes to the bylaws include a new quorum requirement for stockholder meetings, specified advance notice procedures for shareholder proposals, and a revised process for determining shareholder record dates. These corporate developments are part of Ainos, Inc.’s ongoing efforts to keep their investors informed through various channels, including SEC filings, press releases, and social media updates.
For an in-depth examination of AIMD stock, go to TipRanks’ Stock Analysis page.
